Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
  • Patient Engagement
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
Advance your patient engagement strategy

Discover new patient engagement possibilities with IQVIA insights, expertise, and technology-driven solutions.

Patient Engagement Overview
Patient Engagement Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Publication
Evolución del Mercado de la Farmacia Española con datos de Febrero 2021
Mar 15, 2021
To download files you must give consent to process your personal data by clicking the "Accept" button below.

En el acumulado del año 2021 (YTD 02/2021):

Mercado Farmacéutico:
  • Decrece en valores (-2,8%) pero crece en unidades (+1,5%), en cambio, para el MAT 02/21 crece un +3,0% en valores y un +11,3% en unidades - Incluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
  • Decrece en valores y unidades (-7,7% y -11,6% respectivamente), aproximadamente tres veces el decrecimiento en el MAT (-1,9% y -4,4% respectivamente) - Excluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
Mercado de Medicamentos:
  • Decrece en valores y unidades (-8,1% y -12,3% respectivamente), siendo un decrecimiento más leve para el MAT (-2,1% y -5,2% respectivamente)
  • Los productos antidiabéticos son la clase ATC con mayor facturación en el mes de febrero, creciendo más de un 2,5%, seguido por los agentes antitrombóticos, que crecen un 7,0%.
  • Por otro lado, los antitusígenos y antigripales, los productos COPD y antiasmáticos y los antibacterianos sistémicos vuelven a ser, en el mes de febrero, las categorías que acumulan mayores pérdidas en valores.
Mercado de Consumer Health:
  • Crece en valores y unidades (+3,2% y +21,8% respectivamente), siendo un crecimiento del +12,2% y del 43,1% respectivamente para el MAT - Incluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
  • Decrece en valores y unidades (-13,5% y -18,4% respectivamente), presentando un decrecimiento menor en el MAT (-4,5% y -6,2% respectivamente) - Excluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
En el mes de febrero:
  • El segmento PAC es el primero en cuota de mercado, y ello se debe a que sigue siendo el único que crece en unidades y valores, gracias a las mascarillas procedentes de fabricantes que no operan en España.
  • El segmento OTC sigue siendo el que más decrece en valores y unidades debido a la caída de las categorías que componen el mercado del frío (antigripales, anticatarrales, antitusivos y productos para faringe), ocupando la segunda posición en cuota de mercado.
  • El segmento PEC también decrece en valores y unidades. Las categorías que más pérdidas en valores acumulan son los protectores solares y los productos para el cuidado facial femenino, seguido de los productos de cuidado de labios. Sin embargo, crecen en valores las categorías de productos antiseborreicos y colutorios.
  • El segmento NUT decrece en valores y en unidades. La categoría que más aporta al decrecimiento en valores es la de leches para niños. Por otro lado, dietas completas es la que más crecimiento acumula en valores.
  • Las mascarillas, los productos de incontinencia y las dietas completas son las clases con mayor facturación del mercado CH.
Contact Us